LOC388564 Activators
LOC388564 can influence the activity of this protein through various pathways, primarily by modulating the levels of cyclic adenosine monophosphate (cAMP) within the cell. Forskolin, for example, directly stimulates adenylyl cyclase, the enzyme responsible for converting ATP to cAMP. Elevated cAMP levels can lead to the activation of protein kinase A (PKA), which in turn can phosphorylate LOC388564, resulting in its activation. Similarly, Isoproterenol acts as a beta-adrenergic agonist, leading to the activation of adenylyl cyclase through G-protein-coupled receptor signaling, subsequently increasing cAMP and activating PKA. This activation cascade can also phosphorylate LOC388564. IBMX, by inhibiting phosphodiesterases, prevents the breakdown of cAMP, thereby sustaining its levels and ensuring continuous PKA activation and potential downstream activation of LOC388564.
Prostaglandin E1 (PGE1) activates its G-protein-coupled receptors, causing an increase in cAMP and subsequent PKA-mediated phosphorylation of LOC388564. Vardenafil, although primarily a phosphodiesterase type 5 inhibitor, can influence cAMP pathways, leading to PKA activation and LOC388564 phosphorylation. Rolipram and Anagrelide specifically inhibit phosphodiesterase 4 and 3, respectively, leading to increased cAMP levels and PKA activation. Epinephrine, Dopamine, and Terbutaline, through their respective receptors, activate adenylyl cyclase, increasing cAMP and activating PKA, which can then target LOC388564. Histamine, via H2 receptors, also raises cAMP levels, potentially leading to LOC388564 activation via PKA. Lastly, Luteolin, which inhibits PDE4, results in cAMP accumulation and PKA activation, influencing LOC388564 activity. Each of these compounds, through their specific interactions with cellular signaling pathways, can lead to the activation of LOC388564 via the cAMP-PKA axis.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that enhances the production of cAMP by activating adrenergic receptors. The increased cAMP activates PKA, which then could phosphorylate and activate LOC388564 if the protein is a substrate for PKA. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that break down cAMP. By inhibiting these enzymes, IBMX indirectly increases cAMP levels, which can result in the activation of PKA and subsequent activation of LOC388564 if it is regulated by cAMP-dependent phosphorylation. | ||||||
PGE1 (Prostaglandin E1) | 745-65-3 | sc-201223 sc-201223A | 1 mg 10 mg | $31.00 $145.00 | 16 | |
Prostaglandin E1 (PGE1) activates G-protein-coupled receptors, leading to an increase in intracellular cAMP levels. This rise in cAMP can activate PKA, which may then phosphorylate and activate LOC388564 if it is subject to regulation by PKA. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil is a selective inhibitor of cGMP-specific phosphodiesterase type 5 (PDE5). While primarily involved in cGMP pathways, PDE5 inhibitors can also lead to cross-activation of cAMP pathways. Increased cAMP levels could activate PKA, which in turn could phosphorylate and activate LOC388564. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), an enzyme that metabolizes cAMP. Inhibition of PDE4 leads to increased cAMP levels, potentially resulting in PKA activation and phosphorylation of LOC388564 if the protein is a PKA substrate. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Anagrelide inhibits phosphodiesterase 3 (PDE3), leading to increased cAMP levels within cells. The resulting activation of PKA could then lead to the phosphorylation and activation of LOC388564 if it is within the PKA regulatory network. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine binds to and activates beta-adrenergic receptors, which increases cAMP production. Through elevated cAMP, PKA is activated, which could phosphorylate and activate LOC388564, assuming LOC388564 is regulated by PKA-mediated phosphorylation. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to dopamine receptors that are coupled to Gs proteins, leading to increased cAMP levels. This increase can activate PKA, which may phosphorylate and thereby activate LOC388564 if it is a target of PKA. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a beta2-adrenergic agonist that raises cAMP levels by activating beta2-adrenergic receptors. The increase in cAMP may lead to PKA activation, which could phosphorylate and activate LOC388564 if it is a PKA substrate. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H2 receptors, which are positively coupled to adenylyl cyclase via Gs proteins. Activation of these receptors increases cAMP, which activates PKA. PKA may then phosphorylate and activate LOC388564 if it is a target for PKA-dependent phosphorylation. | ||||||